Orka stockholder plans sale of 21,000 shares

Orka shareholder Joana Goncalves plans to sell 21,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with a proposed sale date of 07/15/2026 and an aggregate market value of $1,836,870.00.

Rhea-AI Filing Summary

Orka shareholder Joana Goncalves plans to sell 21,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with a proposed sale date of 07/15/2026 and an aggregate market value of $1,836,870.00. The shares are listed as acquired via exercise of stock options for cash.

Recent activity includes three 10b5-1 sales of Orka common stock: 7,000 shares on 06/15/2026 for $484,610.70, 947 shares on 06/15/2026 for $65,996.43, and 7,000 shares on 05/15/2026 for $432,935.30.

Key Figures

Planned shares to be sold: 21,000 shares Aggregate market value of planned sale: $1,836,870.00 10b5-1 sale on 06/15/2026: 7,000 shares for $484,610.70 +2 more

5 metrics

Planned shares to be sold 21,000 shares Common stock planned for sale on 07/15/2026

Aggregate market value of planned sale $1,836,870.00 Value associated with 21,000 Orka common shares

10b5-1 sale on 06/15/2026 7,000 shares for $484,610.70 Orka common stock sold under 10b5-1

Additional 10b5-1 sale on 06/15/2026 947 shares for $65,996.43 Separate Orka common stock sale

10b5-1 sale on 05/15/2026 7,000 shares for $432,935.30 Earlier Orka common stock transaction

Key Terms

Form 144, 10b5-1 Sales, Exercise of Stock Options, aggregate market value

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Sales regulatory

"10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Common | 07/15/2026 | Exercise of Stock Options | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services 1 New"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What stock sale is planned by Joana Goncalves for Orka (ORKA)?

Joana Goncalves plans to sell 21,000 shares of Orka common stock. The planned transaction is listed with an aggregate market value of $1,836,870.00, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

When is the planned Orka (ORKA) share sale by Joana Goncalves scheduled?

The planned sale of Orka shares is scheduled for 07/15/2026. The notice lists this as the proposed date of sale for the 21,000 common shares to be traded on the NASDAQ market.

What is the aggregate market value of the planned Orka (ORKA) share sale?

The aggregate market value of the planned Orka share sale is $1,836,870.00. This value corresponds to the proposed sale of 21,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

How were the Orka (ORKA) shares to be sold by Joana Goncalves acquired?

The Orka shares to be sold were acquired through an exercise of stock options. The notice describes the acquisition as an exercise of stock options from the issuer, with consideration paid in cash in connection with the 21,000-share position.

What Orka (ORKA) 10b5-1 sales has Joana Goncalves made in the past three months?

Three 10b5-1 sales are listed: 7,000 shares on 06/15/2026 for $484,610.70, 947 shares on 06/15/2026 for $65,996.43, and 7,000 shares on 05/15/2026 for $432,935.30, all in Orka common stock.

Which firm is listed for handling the planned Orka (ORKA) stock sale?

The sale is listed through Morgan Stanley Smith Barney LLC Executive Financial Services. The address provided is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction involves Orka common stock on the NASDAQ market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/15/2026 - 04:31 PM Accepted by SEC EDGAR 07/15/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001756991
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORUKA THERAPEUTICS INC
SEC File Number	000-22873
Address of Issuer	855 Oak Grove Avenue Suite 100 Menlo Park CALIFORNIA 94025
Phone	6506067910
Name of Person for Whose Account the Securities are To Be Sold	JOANA GONCALVES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21000	1836870.00	60312101	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Exercise of Stock Options	Issuer			21000	07/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	06/15/2026	7000	484610.70
JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	06/15/2026	947	65996.43
10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	05/15/2026	7000	432935.30

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joana Goncalves
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)